Premier Biomedical Stock Probability of Future Pink Sheet Price Finishing Under 0.000009
| BIEI Stock | USD 0.0005 0.0001 25.00% |
Premier |
Premier Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Premier Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Premier Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Premier Biomedical had very high historical volatility over the last 90 days | |
| Premier Biomedical has some characteristics of a very speculative penny stock | |
| Premier Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Premier Biomedical currently holds 160.75 K in liabilities. Premier Biomedical has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Premier Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Premier Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Premier Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Premier to invest in growth at high rates of return. When we think about Premier Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 14.28 K. Net Loss for the year was (374.47 K) with profit before overhead, payroll, taxes, and interest of 1.42 K. | |
| Premier Biomedical currently holds about 71.2 K in cash with (344.18 K) of positive cash flow from operations. |
Premier Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Premier Pink Sheet often depends not only on the future outlook of the current and potential Premier Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Premier Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 262.1 M |
Premier Biomedical Technical Analysis
Premier Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Premier Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Premier Biomedical. In general, you should focus on analyzing Premier Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Premier Biomedical Predictive Forecast Models
Premier Biomedical's time-series forecasting models is one of many Premier Biomedical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Premier Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Premier Biomedical
Checking the ongoing alerts about Premier Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Premier Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Premier Biomedical had very high historical volatility over the last 90 days | |
| Premier Biomedical has some characteristics of a very speculative penny stock | |
| Premier Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Premier Biomedical currently holds 160.75 K in liabilities. Premier Biomedical has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Premier Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Premier Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Premier Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Premier to invest in growth at high rates of return. When we think about Premier Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 14.28 K. Net Loss for the year was (374.47 K) with profit before overhead, payroll, taxes, and interest of 1.42 K. | |
| Premier Biomedical currently holds about 71.2 K in cash with (344.18 K) of positive cash flow from operations. |
Other Information on Investing in Premier Pink Sheet
Premier Biomedical financial ratios help investors to determine whether Premier Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Premier with respect to the benefits of owning Premier Biomedical security.